Welcome to our dedicated page for Genesis Heal news (Ticker: GENN), a resource for investors and traders seeking the latest updates and insights on Genesis Heal stock.
Genesis Heal (GENN) delivers essential post-acute care through skilled nursing facilities, senior living communities, and rehabilitation services. This dedicated news hub provides investors and healthcare professionals with timely updates on operational developments, financial milestones, and quality initiatives.
Access verified press releases covering earnings announcements, strategic partnerships, and care quality recognitions. Our curated collection simplifies tracking of leadership changes, service expansions, and industry benchmarking efforts central to GENN's market position.
Key updates include financial performance disclosures, regulatory compliance achievements, and employee development programs. The resource serves as an objective reference for understanding GENN's role in evolving senior care models and post-treatment rehabilitation markets.
Bookmark this page for streamlined monitoring of Genesis Heal's operational trajectory. Combine these verified updates with broader market analysis for comprehensive investment research in the healthcare sector.
Genesis HealthCare has announced that nine of its affiliated nursing facilities received the 2022 Bronze – Commitment to Quality Award from the AHCA/NCAL for their dedication to enhancing resident care. This award represents the first level in a three-tiered recognition program aimed at acknowledging quality improvement in long-term care. The awardees include facilities from multiple states, showcasing Genesis HealthCare's focus on delivering value to residents. The recognition ceremony will take place during the AHCA/NCAL Convention in Nashville, TN, on October 9-12, 2022.
Genesis Healthcare, Inc. (GENN) announced the retirement of James H. Bloem from its Board of Directors, effective January 31, 2022. Bloem had two terms on the board, first from 2001-2003 and later from 2015 until his retirement. The Executive Chairman, David Harrington, expressed gratitude for Bloem's over ten years of service, noting his dedication to guiding the company through various changes. Genesis operates over 250 skilled nursing facilities and provides post-acute care and rehabilitation therapy across the U.S., emphasizing a universal COVID-19 vaccine requirement for staff.
Genesis HealthCare participated in the Alzheimer’s Association’s Walk to End Alzheimer’s, involving nearly 70 teams and raising approximately $100,000 for Alzheimer's support and research. This contribution adds to their lifetime achievement of over $1,000,000 for the cause. With more than 6 million Americans living with the disease, Genesis plays a crucial role in care, operating over 50 facilities with specialized Memory Support units. Their commitment aims to improve the quality of life for those affected by Alzheimer’s and advance research efforts.
Genesis Healthcare announced the appointment of Gerry Adest, CPA, to its Board of Directors effective January 10, 2022. Adest, known for his expertise in the post-acute care industry with over 25 years of experience, succeeds Robert H. Fish, who left the board on January 1, 2022. Executive Chairman David Harrington expressed gratitude for Fish's service and optimism about Adest's contributions to Genesis's future. Genesis operates over 250 skilled nursing and assisted living facilities across 22 states, with a commitment to COVID-19 vaccination for staff.
Genesis HealthCare has announced that 28 of its affiliated skilled nursing facilities have been recognized as Best Nursing Homes for 2021-22 by U.S. News & World Report. This accolade places these facilities in the top 13% nationwide, highlighting their commitment to quality care. The ratings are based on comprehensive data from Nursing Home Compare, focusing on short-term rehabilitation and long-term care. Genesis provides essential services across over 250 facilities and emphasizes staff COVID-19 vaccinations to ensure patient safety.
Genesis Healthcare (OTC: GENN) announced a shift to a market-focused model aimed at creating a vertically integrated healthcare system. This reorganization emphasizes local centers and dedicated teams to improve services for residents and patients. Several leadership changes were also disclosed, as Chief Operating Officer Paul Bach, Chief Nursing Officer JoAnne Reifsnyder, and Chief Financial Officer Tom DiVittorio are set to leave the company. New appointments include Melissa Powell as COO and Orrin Feingold as CFO, tasked with executing a 100-day plan to enhance revenue and reduce costs.
Genesis Healthcare, Inc. (GENN) announced the upcoming departure of CEO Harry Wilson, effective November 15, 2021, along with his consulting firm, MAEVA Group. Under Wilson's leadership, a restructuring plan was successfully implemented, improving the company's financial situation. The Board of Directors will now search for a new CEO while the existing senior leadership continues executing the turnaround. Chairman David Harrington commended Wilson for his significant contributions and focused efforts during his tenure.
Genesis HealthCare (OTC PINK: GENN) announced a universal COVID-19 vaccination requirement for employees and onsite vendors, effective August 23, 2021. This policy aims to protect at-risk nursing home patients amid rising Delta variant cases. Genesis has achieved over 85% vaccination among residents and 65% among staff since starting voluntary vaccinations in December 2020. The decision aligns with broader calls for mandatory vaccinations within healthcare settings to ensure patient safety and well-being.
Genesis HealthCare achieved a significant milestone on April 19, 2021, by completing its millionth point-of-care (POC) COVID-19 test. These tests were conducted across over 300 skilled nursing and assisted living facilities nationwide. POC tests provide rapid results within an hour, greatly aiding in the fight against COVID-19 by allowing for timely screening of patients and staff. Genesis established more than 300 clinically approved labs in 22 states and invested millions in testing equipment. The labs remain operational to ensure safety as facilities reopen.
